BioVaxys Technology (TSE:BIOV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioVaxys Technology Corp.’s partner, SpayVac for Wildlife, Inc., has expanded its vaccine production capacity at its Madison facility, enabling it to meet the needs of global animal population control projects. This expansion supports the launch of new contraceptive vaccines and enhances SpayVac’s ability to deliver single-dose, multi-year fertility-control solutions for wildlife and agricultural animals.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.